GlassScriptPhysician profile
Herbert S Coussons
NPI 1427007624
$101,168.06
in general payments reported to CMS, 2019-2025
23 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34K · 2020: $18K · 2021: $38K · 2022: $11K · 2023: $418 · 2024: $212 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $875.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $80,483.35 | 2019-2024 | Orilissa |
| Intuitive Surgical, INC. | $13,816.98 | 2019-2023 | Da Vinci Surgical System |
| Pfizer INC. | $4,893.73 | 2019-2024 | |
| Stryker Corporation | $808.83 | 2019 | |
| Sumitomo Pharma America, INC. | $492.25 | 2023-2025 | Myfembree, Gemtesa |
| Myovant Sciences INC. | $116.44 | 2021-2022 | |
| Ibsa Pharma INC. | $98.10 | 2022-2024 | Tirosint, Licart, Tirosint |
| Amag Pharmaceuticals, INC. | $61.50 | 2019 | |
| Hologic Sales and Service, LLC | $60.13 | 2020-2024 | Acessa Provu System |
| Therapeuticsmd, INC. | $57.01 | 2019-2021 | |
| Astellas Pharma US INC | $48.33 | 2023-2024 | Veozah |
| Lilly USA, LLC | $41.37 | 2025 | Mounjaro, Zepbound |
| Roche Diagnostics Corporation | $34.53 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.30 | 2021 | |
| Medtronic, INC. | $19.10 | 2024 | V-Loc 180 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $18.07 | 2022 | |
| Urgo Medical North America, LLC | $16.87 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Pacira Pharmaceuticals Incorporated | $15.67 | 2019 | |
| Ethicon US, LLC | $14.97 | 2022 | |
| Axonics, INC. | $13.79 | 2023 | Axonics |
| Novo Nordisk INC | $12.97 | 2023 | |
| Daiichi Sankyo INC. | $12.84 | 2019 | |
| Merck Sharp & Dohme LLC | $11.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herbert Coussons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.